Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$13.35
-4.0%
$15.04
$12.76
$27.28
$132.35M1.01126,216 shs108,701 shs
Pulmonx Corporation stock logo
LUNG
Pulmonx
$1.61
-12.5%
$2.91
$1.59
$9.37
$74.07M0.43649,469 shs1.87 million shs
Avita Medical Inc. stock logo
RCEL
Avita Medical
$5.16
-2.6%
$5.59
$4.71
$14.16
$140.10M1.63255,325 shs321,032 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$5.18
+19.6%
$3.85
$1.97
$7.95
$25.50M7.03428,007 shs981,899 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-4.03%-10.76%-2.20%-20.72%-43.43%
Pulmonx Corporation stock logo
LUNG
Pulmonx
-12.50%-51.80%-40.81%-57.29%-76.70%
Avita Medical Inc. stock logo
RCEL
Avita Medical
-2.64%-10.57%-0.19%-44.16%-47.35%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
+19.63%-1.15%+35.25%+89.74%+125.22%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
4.4608 of 5 stars
3.51.00.84.90.03.32.5
Pulmonx Corporation stock logo
LUNG
Pulmonx
3.855 of 5 stars
4.33.00.00.02.33.31.3
Avita Medical Inc. stock logo
RCEL
Avita Medical
0.9866 of 5 stars
3.40.00.00.00.60.00.6
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
0.7156 of 5 stars
1.32.00.00.03.20.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
3.00
Buy$26.0094.76% Upside
Pulmonx Corporation stock logo
LUNG
Pulmonx
2.56
Moderate Buy$7.66376.04% Upside
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.75
Moderate Buy$16.50219.77% Upside
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.50
Moderate Buy$4.82-7.01% Downside

Current Analyst Ratings Breakdown

Latest VVOS, RCEL, LAKE, and LUNG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/1/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$6.00 ➝ $3.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$12.00 ➝ $8.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$16.00 ➝ $5.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $16.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$9.00 ➝ $2.50
6/10/2025
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$30.00 ➝ $26.00
6/6/2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$19.00
5/22/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$6.50 ➝ $4.15
5/20/2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Industrial Alliance Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$2.25
5/20/2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$177.65M0.72$1.02 per share13.03$15.44 per share0.86
Pulmonx Corporation stock logo
LUNG
Pulmonx
$83.79M0.77N/AN/A$2.17 per share0.74
Avita Medical Inc. stock logo
RCEL
Avita Medical
$64.25M2.12N/AN/A$0.17 per share30.35
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$15.03M2.03N/AN/A$1.35 per share3.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-$18.08M-$3.01N/A8.04N/A-13.31%-6.88%-4.47%9/3/2025 (Estimated)
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$56.39M-$1.43N/AN/AN/A-62.88%-66.36%-35.51%N/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$61.85M-$2.19N/AN/AN/A-79.61%-632.62%-71.72%8/7/2025 (Estimated)
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$11.14M-$1.73N/AN/AN/A-76.82%-170.43%-77.82%8/13/2025 (Estimated)

Latest VVOS, RCEL, LAKE, and LUNG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.39N/AN/AN/A$3.37 millionN/A
8/7/2025Q2 2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$0.26N/AN/AN/A$34.27 millionN/A
7/30/2025Q2 2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.40-$0.38+$0.02-$0.38$23.46 million$23.86 million
6/9/2025Q1 2026
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.27-$0.41-$0.68-$0.41$48.84 million$46.75 million
5/15/2025Q1 2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.44-$0.45-$0.01-$0.45$3.63 million$3.70 million
5/8/2025Q1 2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$0.39-$0.53-$0.14-$0.53$33.15 million$18.51 million
5/7/2025Q1 2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.37-$0.36+$0.01-$0.36$22.03 million$22.54 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.120.90%N/AN/A 1 Years
Pulmonx Corporation stock logo
LUNG
Pulmonx
N/AN/AN/AN/AN/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
N/AN/AN/AN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
0.17
3.88
1.51
Pulmonx Corporation stock logo
LUNG
Pulmonx
0.38
4.97
4.29
Avita Medical Inc. stock logo
RCEL
Avita Medical
9.39
2.09
1.72
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/A
0.77
0.77

Institutional Ownership

CompanyInstitutional Ownership
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
71.69%
Pulmonx Corporation stock logo
LUNG
Pulmonx
91.04%
Avita Medical Inc. stock logo
RCEL
Avita Medical
27.66%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
26.35%

Insider Ownership

CompanyInsider Ownership
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
1.91%
Pulmonx Corporation stock logo
LUNG
Pulmonx
6.80%
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.80%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
3.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
2,1009.52 million9.33 millionOptionable
Pulmonx Corporation stock logo
LUNG
Pulmonx
25040.26 million37.52 millionOptionable
Avita Medical Inc. stock logo
RCEL
Avita Medical
13026.43 million25.70 millionOptionable
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
1605.89 million5.71 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Lakeland Industries stock logo

Lakeland Industries NASDAQ:LAKE

$13.35 -0.56 (-4.03%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$13.36 +0.01 (+0.04%)
As of 08/1/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.

Pulmonx stock logo

Pulmonx NASDAQ:LUNG

$1.61 -0.23 (-12.50%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.67 +0.06 (+3.66%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Avita Medical stock logo

Avita Medical NASDAQ:RCEL

$5.16 -0.14 (-2.64%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$5.17 +0.01 (+0.27%)
As of 08/1/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Vivos Therapeutics stock logo

Vivos Therapeutics NASDAQ:VVOS

$5.18 +0.85 (+19.63%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$5.18 0.00 (-0.10%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.